VIA
TYRA icon

Virtus Investment Advisers’s Tyra Biosciences TYRA Stock Holding History

Virtus Investment Advisers’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$387K Buy
12,123
+74
+0.6% +$2.45K 0.09% 298
2026
Q1 		$461K Buy
12,049
+293
+2% +$9.48K 0.13% 227
2025
Q4 		$309K Buy
11,756
+741
+7% +$13.6K 0.08% 251
2025
Q3 		$154K Buy
11,015
+1,912
+21% +$21.8K 0.04% 372
2025
Q2 		$87.1K Sell
9,103
-1,715
-16% -$16.3K 0.03% 396
2025
Q1 		$101K Buy
+10,818
New +$140K 0.03% 419

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Virtus Investment Advisers's TYRA Position: Q2 2026 in Review

Virtus Investment Advisers increased its Tyra Biosciences (TYRA) stake by 0.61% in Q2 2026, buying an estimated $2.45K and bringing the position to 12,123 shares worth $387K. The position accounts for 0.09% of the portfolio, ranked #298.

Virtus Investment Advisers first reported a position in TYRA in Q1 2025 and has held it in 6 quarters since. The position peaked at $461K in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Virtus Investment Advisers held 12,123 shares of Tyra Biosciences worth $387K as of Q2 2026.
  • Virtus Investment Advisers bought 74 Tyra Biosciences shares in Q2 2026, an estimated $2.45K.
  • Tyra Biosciences made up 0.09% of Virtus Investment Advisers's portfolio in Q2 2026, its #298 holding.
  • Virtus Investment Advisers first reported a position in Tyra Biosciences in Q1 2025 and has held it in 6 quarters since.
  • Virtus Investment Advisers's Tyra Biosciences position peaked at $461K in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.